Haran J P, Wu G, Bucci V, Fischer A, Keang L, Boyer E W, Hibberd P L
Department of Emergency Medicine,University of Massachusetts Medical School,Worcester,MA,USA.
Department of Biology,University of Massachusetts Dartmouth,North Dartmouth,MA,USA.
Epidemiol Infect. 2016 Jul;144(10):2176-83. doi: 10.1017/S0950268816000200.
Clostridium difficile diarrhoea is an urgent threat to patients, but little is known about the role of antibiotic administration that starts in emergency department observation units (EDOUs). We studied risk factors for antibiotic-associated diarrhoea (AAD) and C. difficile infection (CDI) in EDOU patients. This prospective cohort study enrolled adult patients discharged after EDOU antibiotic treatment between January 2013 and 2014. We obtained medical histories, EDOU treatment and occurrence of AAD and CDI over 28 days after discharge. We enrolled and followed 275 patients treated with antibiotics in the EDOU. We found that 52 (18·6%) developed AAD and four (1·5%) had CDI. Patients treated with vancomycin [relative risk (RR) 0·52, 95% confidence interval (CI) 0·3-0·9] were less likely to develop AAD. History of developing diarrhoea with antibiotics (RR 3·11, 95% CI 1·92-5·03) and currently failing antibiotics (RR 1·90, 95% CI 1·14-3·16) were also predictors of AAD. Patients with CDI were likely to be treated with clindamycin. In conclusion, AAD occurred in almost 20% of EDOU patients with risk factors including a previous history of diarrhoea with antibiotics and prior antibiotic therapy, while the risk of AAD was lower in patients receiving treatment regimens utilizing intravenous vancomycin.
艰难梭菌腹泻对患者构成了紧迫威胁,但对于在急诊科观察病房(EDOU)开始的抗生素使用所起的作用知之甚少。我们研究了EDOU患者中抗生素相关性腹泻(AAD)和艰难梭菌感染(CDI)的危险因素。这项前瞻性队列研究纳入了2013年1月至2014年间在EDOU接受抗生素治疗后出院的成年患者。我们获取了他们的病史、EDOU治疗情况以及出院后28天内AAD和CDI的发生情况。我们纳入并随访了275名在EDOU接受抗生素治疗的患者。我们发现52例(18.6%)发生了AAD,4例(1.5%)发生了CDI。接受万古霉素治疗的患者发生AAD的可能性较小[相对危险度(RR)0.52,95%置信区间(CI)0.3 - 0.9]。有抗生素相关性腹泻病史(RR 3.11,95% CI 1.92 - 5.03)以及当前抗生素治疗效果不佳(RR 1.90,95% CI 1.14 - 3.16)也是AAD的预测因素。发生CDI的患者可能接受了克林霉素治疗。总之,近20%的EDOU患者发生了AAD,危险因素包括既往有抗生素相关性腹泻病史和先前的抗生素治疗,而接受静脉用万古霉素治疗方案的患者发生AAD的风险较低。